TG Therapeutics Inc (TGTX)
Number of days of payables
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Payables turnover | — | — | — | — | — | |
| Number of days of payables | days | — | — | — | — | — |
December 31, 2024 calculation
Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ —
= —
The data provided for TG Therapeutics Inc's number of days of payables from December 31, 2020 through December 31, 2024 shows that the specific number of days of payables is not available or has not been disclosed for these periods. The lack of this information makes it challenging to assess the efficiency of the company in managing its payables and the related impact on its liquidity position. Further data would be necessary to conduct a thorough analysis of the payables turnover and its implications for the company's overall financial health and operations.
Peer comparison
Dec 31, 2024
Company name
Symbol
Number of days of payables
TG Therapeutics Inc
TGTX
—
Abbott Laboratories
ABT
49.95
AbbVie Inc
ABBV
29.64
ACADIA Pharmaceuticals Inc
ACAD
153.78
Alkermes Plc
ALKS
18.68
Amphastar P
AMPH
31.10
ANI Pharmaceuticals Inc
ANIP
33.22
Arcus Biosciences Inc
RCUS
43.80
Biomarin Pharmaceutical Inc
BMRN
—
Bristol-Myers Squibb Company
BMY
41.38
Catalyst Pharmaceuticals Inc
CPRX
24.74